Dabigatran, marketed as Pradaxa, is a prescription medication used to reduce the risk of stroke and systemic embolism in people with non-valvular atrial fibrillation, and to treat venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE) [1]. It is also used to prevent VTE in people who have just had hip or knee replacement surgery [1].
When Might Generic Dabigatran Become Available?
The availability of generic versions of dabigatran depends on patent expirations and any potential legal challenges to those patents [2]. Drug patent information is publicly available and tracked, offering insights into when market exclusivity might end [2].
What Companies Are Involved with Dabigatran?
Dabigatran was developed by Boehringer Ingelheim [3]. Boehringer Ingelheim is the originator company of Pradaxa.
What Are Dabigatran's Key Uses?
Dabigatran is prescribed to [1]:
* Reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
* Treat venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE).
* Prevent VTE in individuals recovering from hip or knee replacement surgery.
How Does Dabigatran Work?
Dabigatran is a direct thrombin inhibitor [1]. Thrombin is a key enzyme in the blood clotting cascade, and by inhibiting it, dabigatran prevents the formation of blood clots [1].
What Are the Potential Side Effects of Dabigatran?
The most significant risk associated with dabigatran, like other anticoagulants, is bleeding [1]. Other side effects can include indigestion and abdominal pain [1].
How is Dabigatran Administered?
Dabigatran is taken orally in capsule form [1].
What Alternatives Exist for Anticoagulation?
Other anticoagulant medications are available, including warfarin (Coumadin), rivaroxaban (Xarelto), apixaban (Eliquis), and edoxaban (Savaysa) [4]. Each of these drugs has its own mechanism of action, administration, monitoring requirements, and potential side effects [4].
Sources:
[1] https://www.drugpatentwatch.com/drug/dabigatran/
[2] https://www.drugpatentwatch.com/
[3] https://www.boehringer-ingelheim.com/
[4] https://www.nhs.uk/medicines/blood-thinners/